Hyperkalemia: Prevalence, Predictors and Emerging Treatments

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Hyperkalemia, or elevated potassium, is linked to increased morbidity, mortality, and healthcare costs.
• It frequently occurs in patients with chronic kidney disease, diabetes, and heart failure.
• Renin-angiotensin-aldosterone system inhibitors (RAASi), crucial for managing these conditions, can elevate potassium levels.

Purpose of the Study:

• To review the definition, causes, epidemiology, and consequences of hyperkalemia.
• To focus on contemporary management strategies for hyperkalemia in both acute and chronic settings.
• To discuss evolving data on dietary modifications and novel potassium binders.

Main Methods:

• Literature review of hyperkalemia definition, causes, and consequences.
• Analysis of current and emerging hyperkalemia management approaches.
• Evaluation of evidence regarding dietary potassium restriction and new potassium binders.

Main Results:

• Hyperkalemia poses significant risks, particularly in patients with common chronic diseases.
• Optimizing RAASi treatment requires careful balancing with hyperkalemia risk mitigation.
• Dietary management and novel potassium binders represent evolving strategies.

Conclusions:

• Effective hyperkalemia management is essential for optimizing patient care, especially those on RAASi.
• A comprehensive approach integrating risk assessment, monitoring, and therapeutic interventions is necessary.
• Further research into dietary interventions and novel binders will refine clinical practice.